TU:NYSETelus Corporation Analysis
Data as of 2026-09-10 - not real-time
$9.46
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
TELUS Corporation trades at $9.46, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. Across the trailing 30 sessions it lost 11.5%. With RSI at 37.3 the momentum picture is approaching oversold, alongside a bullish MACD signal. Price has been bracketed by support at $9.44 and resistance at $10.11.
Multiples put this in fair territory: 17.4 times earnings against the sector's 15.3. Analyst price targets sit 9.2% above the current price. Revenue is contracting at 2.2% on a -4.5% profit margin. The 5.55% dividend yield looks stretched against payout coverage.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 42.5%, a beta of 0.02 and a maximum drawdown of 41.1%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
All three time horizons resolve to hold, carrying 3/10 conviction.
Multiples put this in fair territory: 17.4 times earnings against the sector's 15.3. Analyst price targets sit 9.2% above the current price. Revenue is contracting at 2.2% on a -4.5% profit margin. The 5.55% dividend yield looks stretched against payout coverage.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 42.5%, a beta of 0.02 and a maximum drawdown of 41.1%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
All three time horizons resolve to hold, carrying 3/10 conviction.
Top Market Events
Yahoo Finance1monTelus Corporation TU Q2 FY2026 earnings call transcriptTELUS reported Q2 2026 service revenue of CAD 4.Yahoo Finance1monTELUS Corp TU Q2 2026 Earnings Call Highlights: Strategic Reset and AI-Driven TransformationThe above...Seeking Alpha1monTELUS Corporation T:CA Q2 2026 Earnings Call TranscriptGood day, everyone.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 12.19
- MACD momentum is positive
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked below long-term ones
- P/E of 17.4 versus sector average of 15.3
- Dividend yield of 5.55% looks stretched against payout coverage
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 17.4 versus sector average of 15.3
- Dividend yield of 5.55% looks stretched against payout coverage
- Negative profit margin of -4.5%
Key Metrics & Analysis
Financial Health
Revenue Growth-2.20%
Profit Margin-4.55%
P/E Ratio17.4
ROE-6.39%
ROA3.41%
Debt/Equity223.81
P/B Ratio1.5
Op. Cash Flow$5.0B
Free Cash Flow$2.4B
Industry P/E15.3
Technical Analysis
TrendBearish
RSI37.3
Support$9.44
Resistance$10.11
MA 20$9.72
MA 50$10.03
MA 200$12.19
MACDBullish
VolumeStable
Fear & Greed Index92.04
Valuation
Fair Value$0.05
Target Price$10.33
Upside/Downside9.23%
GradeFair
TypeValue
Dividend Yield5.55%
Risk Assessment
Beta0.02
Volatility42.48%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.